Abstract
Female sex hormones also affect the mouth but there are little data on oral health of menopause age women. This 2-year follow-up study investigated oral health of perimenopausal and early postmenopausal women. Because hormone replacement therapy (HRT) users have been reported to be more health conscious than nonusers, we expected differences between women using and women not using HRT. Of 3,173 women, a random sample of 400 (200 using and 200 not using HRT) was examined. Of them, 161 case–control pairs of women using/not using HRT were reexamined 2 years later. Dental and periodontal status was recorded according to the WHO criteria and resting and stimulated saliva flow was measured. Panoramic tomography of the jaws was taken at baseline and at follow-up. The patients also filled in a structured questionnaire on their systemic health, medication, and health habits. The results were analyzed statistically between and within the groups. No difference was observed in any dental parameters or salivary flow rates between the groups. However, during the follow-up, women in HRT group had received more dental restorations (p < 0.05) and they also reported more often recent dental appointments (p < 0.05). Although no difference in oral health status or salivary flow rates between women using or not using HRT was found, the observation on dental restorations may indicate a more health conscious attitude in the HRT group.
Similar content being viewed by others
References
Ahlberg J, Tuominen R, Murtomaa H (1996) Periodontal status among male industrial workers in southern Finland with or without access to subsidized dental care. Acta Odontol Scand 54:166–170
Ainamo J, Barmes D, Beagrie G, Cutress T, Martin J, Sardo-Infirri J (1982) Development of the World Health Oranization (WHO) Community Periodontal Index of Treatment Need (CPITN). Int Dent J 32:281–291
Ajwani S, Tervonen T, Närhi T, Ainamo A (2001) Periodontal health status and treatment needs among elderly. Spec Care Dentist 21:98–103
Arafat AH (1974) Periodontal status during pregnancy. J Periodontol 45:641–643
Bergdahl M (2000) Salivary flow and oral complaints in adult dental patients. Community Dent Oral Epidemiol 28:59–66
Brace M, McCauley E (1997) Oestrogens and psychological well-being. Ann Med 29:283–290
Cherry N, Gilmour K, Hannaford P, Heagerty A, Khan MA, Kitchener H, McNamee R, Elstein M, Kay C, Seif M, Buckley H (2002) Oestrogen therapy for prevention of reinfarction in postmenopausal women: a randomised placebo controlled trial. Lancet 360:2001–2008
Cutress TW, Ainamo J, Sardo-Infirri J (1987) The Community Periodontal Index of Treatment Needs (CPITN) procedure for population groups and individuals. Int Dent J 37:222–233
Dural S, Cağirankaya LB (2007) Does menstrual cycle effect buffer capacity of stimulated saliva? Clin Oral Investig 11:207–209
Evio S, Tarkkila L, Sorsa T, Furuholm J, Valimaki M, Ylikorkala O, Tiitinen A, Meurman J (2006) Effects of alendronate and hormone replacement therapy, alone and in combination, on saliva, periodontal conditions and gingival crevicular fluid matrix metalloproteinase-8 levels in women with osteoporosis. Oral Dis 12:187–193
Friedlander AH (2002) The physiology, medical management and oral implications of menopause. J Am Dent Assoc 133:73–81
Frutos R, Rodriguez S, Miralles-Jorda L, Machuca G (2002) Oral manifestations and dental treatment in menopause. Med Oral 7:26–35
Fure S, Zickert I (1997) Incidence of tooth loss and dental caries in 60-, 70-, and 80-year-old Swedish individuals. Community Dent Oral Epidemiol 25:137–142
Grodstein F, Colditz GA, Stampfer MJ (1998) Tooth loss and hormone use in postmenopausal women. Compend Contin Educ Dent 22:S9–S16
Grodstein F, Stampfer R (1995) The epidemiology of coronary heart disease and estrogen replacement in postmenopausal women. Prog Cardiovasc Dis 38:199–121
Hemminki E, Malin M, Topo P (1993) Selection to postmenopausal therapy by women’s characteristics. J Clin Epidemiol 46:211–219
Herrington DM, Reboussin DM, Brosnihan KB, Sharp PC, Shumaker SA, Snyder TE, Furberg CD, Kowalchuk GJ, Stuckey TD, Rogers WJ, Givens DH, Waters D (2000) Effects of estrogen replacement on the progression of coronary-artery atherosclerosis. N Engl J Med 343:522–529
Hildebrandt CG, Loesche WJ, Lin CF, Bretz WA (1995) Comparison of the number and type of dental functional units in geriatric populations with diverse medical backgrounds. J Prosthet Dent 73:253–261
Janket SJ, Baird A, Chuang S, Jones JA (2003) Meta-analysis of periodontal disease and risk of coronary heart disease and stroke. Oral Surg Oral Med Oral Pathol Oral Radiol Endo 95:559–569
Klock B, Svanberg M, Petersson LG (1990) Dental caries, mutans streptococci, lactobacilli, and saliva secretion rate in adults. Community Dent Oral Epidemiol 18:249–252
Laine M (2002) Effect of pregnancy on periodontal and dental health (review). Acta Odontol Scand 60:257–264
Löe H, Silness J (1963) Periodontal disease in pregnancy. Prevalence and severity. Acta Odontol Scand 21:533–551
Loesche WJ, Schork A, Terpenning MS, Chen Y-M, Stoll J (1995) Factors which influence levels of selected organism in saliva of older individuals. J Clin Microbiol 33:2550–2557
Mariotti A (1994) Sex steroid hormones and cell dynamics in the periodontium. Critic Rev Oral Biol Med 5:27–53
Matthews KA (1992) Myths and realities of the menopause. Psychosom Med 54:1–9
Matthews KA, Kuller LH, Wing RR, Meilahn EN, Plantinga P (1996) Prior to use estrogen replacement therapy, are users healthier than nonusers? Am J Epidemiol 143:971–978
Meurman JH, Rantonen P (1994) Salivary flow rate, buffering capacity, and yeast counts in 187 consecutive adult patients from Kuopio, Finland. Scand J Dent Res 102:229–234
Meurman JH, Furuholm J, Kaaja R, Rintamäki H (2006) Oral health in women with pregnancy and delivery complications. Clin Oral Invest 10:96–101
Ogawa H, Yoshihara A, Hirotomi T, Ando Y, Miyazaki H (2002) Risk factors for periodontal disease progression among elderly people. J Clin Periodontol 29:592–597
Pajukoski H, Meurman JH, Snellman-Gröhn S, Sulkava R (1999) Oral health in hospitalized and nonhospitalized community dwelling elderly patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endo 88:437–443
Pilgram TK, Hildebolt CF, Dotson M, Cohen SC, Hauser JF, Kardaris E, Civitelli R (2002) Relationships between clinical attachment level and spine and hip bone mineral density: data from healthy postmenopausal women. J Periodontol. 73:298–301
Powell LV, Leroux BG, Persson RE, Kiyak HA (1998) Factors associated with caries incidence in an elderly population. Community Dent Oral Epidemiol 26:170–176
Reinhard RA, Payne JB, Maze CA, Patil KD, Gallagher SJ, Mattson JS (1999) Influence of estrogen and osteopenia/osteoporosis on clinical periodontitis in postmenopausal women. J Periodontol 70:823–828
Schuller AA, Holst D (1998) Changes in the oral health of adults from Trondelag, Norway, 1973–1983–1994. Community Dent Oral Epidemiol 26:201–208
Seeman E, Tsalamandris C, Bass S, Pearce G (1995) Present and future osteoporosis therapy. Bone 17:235–295
Söder P-Ö, Jin LJ, Söder B, Wikner S (1994) Periodontal status in an urban adult population in Sweden. Community Dent Oral Epidemiol 22:106–111
Soory M (2000) Targets for steroid hormone mediated actions of periodontal pathogens, cytokines and therapeutic agents: some implications on tissue turnover in the periodontium. Curr Drug Targets 1:309–325
Tarkkila L, Linna M, Tiitinen A, Lindqvist C, Meurman JH (2001) Oral symptoms at menopause—the role of hormone replacement therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endo 92:276–280
Tonnetti MS (1998) Cigarette smoking and periodontal diseases: etiology and management of disease. Ann Periodontol 3:88–101
Topo P, Klaukka T, Hemminki E, Uutela A (1991) Use of hormone replacement therapy in 1976–1989 by 45–64 year old Finnish women. J Epidemiol Community Health 45:277–280
Topo P, Luoto R, Hemminki E, Uutela A (1999) Declining socioeconomic differences in the use of menopausal and postmenopausal hormone therapy in Finland. Maturitas 32:141–145
Unell L, Söderfeldt B, Halling A, Birkhed D (2000) Explanatory models for clinical and subjective indicators of periodontal disease in an adult population. J Clin Periodontol 27:22–29
World Health Organization (1997) Oral health surveys, 5thth edn. WHO, Geneva
Writing Group for the Women’s Health Initiative Investigators (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women’s Health Initiative randomized controlled trial. J Am Med Assoc 288:321–333
Yalcin F, Gurgan S, Gurgan T (2005) The effect of menopause, hormone replacement therapy (HRT), alendronate (ALN), and calcium supplements on saliva. J Contemp Dent Pract 6:10–17
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tarkkila, L., Furuholm, J., Tiitinen, A. et al. Oral health in perimenopausal and early postmenopausal women from baseline to 2 years of follow-up with reference to hormone replacement therapy. Clin Oral Invest 12, 271–277 (2008). https://doi.org/10.1007/s00784-008-0190-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00784-008-0190-z